Crossmark

Serum and cerebrospinal fluid Neudesin concentration and Neudesin Quotient as potential circulating biomarkers of a primary brain tumor

Crossref DOI link: https://doi.org/10.1186/s12885-019-5525-4

Published Online: 2019-04-05

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Koper-Lenkiewicz, Olga M. https://orcid.org/0000-0001-5199-2773
Kamińska, Joanna

Milewska, Anna

Sawicki, Karol

Jadeszko, Marek

Mariak, Zenon

Reszeć, Joanna

Dymicka-Piekarska, Violetta

Matowicka-Karna, Joanna
License Information

Text and Data Mining valid from 2019-04-05
More Information

Article History

Received: 23 October 2018

Accepted: 26 March 2019

First Online: 5 April 2019

Ethics approval and consent to participate

: The study was approved by the Bioethics Human Research Committee of the Medical University of Bialystok (Permission No. R-I-002/383/2015) and was conducted in agreement with the Helsinki-II-declaration. All subjects included in the study gave their informed written consent.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.